Communications BiologyBioinformaticsPeer-reviewed journal article
The Role of C-to-U RNA Editing in Human Biodiversity
Melissa Van NordeniD, Zackary FallsiD, Sapan MandloiiD, Brahm H. SegaliD, Bora E. BaysaliD, Ram SamudralaiD, Peter L. ElkiniD
Abstract
Intra-organism biodiversity is thought to arise from epigenetic modification of our constituent genes and post-translational modifications after mRNA is translated into proteins. We have found that post-transcriptional modification, also known as RNA editing, is also responsible for a significant amount of our biodiversity, substantively expanding this story. The APOBEC (apolipoprotein B mRNA editing catalytic polypeptide-like) family RNA editing enzymes APOBEC3A and APOBEC3G catalyze the deamination of cytosines to uracils (C>U) in specific stem-loop structures.1,2 We used RNAsee (RNA site editing evaluation), a tool developed to predict the locations of APOBEC3A/G RNA editing sites, to determine whether known single nucleotide polymorphisms (SNPs) in DNA could be replicated in RNA via RNA editing. About 4.5% of non-synonymous SNPs which result in C>U changes in RNA, and about 5.4% of such SNPs labelled as pathogenic, were identified as probable sites for APOBEC3A/G editing. This suggests that the variant proteins created by these DNA mutations may also be created by transient RNA editing, with the potential to affect human health. Those SNPs identified as potential APOBEC3A/G-mediated RNA editing sites were disproportionately associated with cardiovascular diseases, digestive system diseases, and musculoskeletal diseases. Future work should focus on common sites of RNA editing, any variant proteins created by these RNA editing sites, and the effects of these variants on protein diversity and human health. Classically, our biodiversity is thought to come from our constitutive genetics, epigenetic phenomenon, transcriptional differences, and post-translational modification of proteins. Here, we have shown evidence that RNA editing, often stimulated by environmental factors, could account for a significant degree of the protein biodiversity leading to human disease. In an era where worries about our changing environment are ever increasing, from the warming of our climate to the emergence of new diseases to the infiltration of microplastics and pollutants into our bodies, understanding how environmentally sensitive mechanisms like RNA editing affect our own cells is essential.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 16
- FWCI
- 2.18
- Field percentile
- top 11%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- APOBEC3A is the predominant global editor of cytosines in human mRNAs and in single-strand RNA viruses
Zachary W. Kockler, Hamed Bostan, … Dmitry A. Gordenin·G3 Genes Genomes GeneticsPeer-reviewed·Mar 28, 2026
- Acute expression of human APOBEC3B in mice causes lethality associated with RNA editing
Alicia Alonso de la Vega, Nuri A. Temiz, … Rocı́o Sotillo·bioRxiv·Jun 1, 2022
- APOBEC1 mediated C-to-U RNA editing: target sequence and trans-acting factor contribution to 177 RNA editing events in 119 murine transcripts in-vivo
Saeed Soleymanjahi, Valérie Blanc, Nicholas O. Davidson·RNAPeer-reviewed·Jun 3, 2021
- Mutation bias implicates RNA editing in a wide range of mammalian RNA viruses
Peter Simmonds K, M. Azim Ansari·bioRxiv·Feb 9, 2021
- MultiEditR: An easy validation method for detecting and quantifying RNA editing from Sanger sequencing
Mitchell G. Kluesner, Rafail Nikolaos Tasakis, … Riccardo Pecori·Molecular Therapy — Nucleic AcidsPeer-reviewed·Jul 21, 2021
- Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables.
Edoardo Giacopuzzi, Massimo Gennarelli, … Alessandro Barbon·BMC GenomicsPeer-reviewed·Dec 1, 2018